前部缺血性视神经病变(AION)联合立场声明:西班牙内科学会(SEMI)血管风险组与全身自身免疫病组(GEAS)及西班牙视网膜与玻璃体学会(SERV)
该立场声明由西班牙内科学会(SEMI)血管风险组与全身自身免疫病组(GEAS)及西班牙视网膜与玻璃体学会(SERV)联合制定,旨在为前部缺血性视神经病变(AION)的临床管理建立基于共识的建议。AION分为动脉炎型(最常见与巨细胞动脉炎相关,构成内科与眼科急症)和非动脉炎型(更常见,目前无特异性有效治疗)。声明批判性回顾了AION的流行病学、病理生理、诊断和治疗方面,并提供实用建议以改善早期发现、病因管理及视觉和全身并发症的预防,特别强调内科医生在这些患者照护中的作用。文中建议应被解读为基于专家共识的建议,尤其是在缺乏高质量证据的部分。
要点
- AION是50岁以上人群突发、无痛性单眼视力丧失的主要原因之一,需区分动脉炎型与非动脉炎型。
- 动脉炎型AION最常与巨细胞动脉炎相关,构成内科与眼科急症。
- 非动脉炎型AION远为更常见,目前尚无特异性有效治疗。
- AION管理仍存在异质性,护理路径、病因评估及随访和二级预防策略变异较大,需眼科与内科紧密协作。
- 声明中的建议应解读为基于专家共识的建议,尤其在缺乏高质量证据的部分。
适用人群与场景
- 50岁以上突发、无痛性单眼视力丧失的个体。
- 动脉炎型AION患者,最常与巨细胞动脉炎相关。
- 非动脉炎型AION患者,该类远为更常见。
红旗征与不能漏的情况
- 动脉炎型AION构成内科与眼科急症。
研究设计与关键结果
- 制定机构:西班牙内科学会(SEMI)血管风险组与全身自身免疫病组(GEAS)及西班牙视网膜与玻璃体学会(SERV)。
- 方法:批判性回顾AION的流行病学、病理生理、诊断和治疗方面,提供共识建议。
- 证据分级体系:声明中的建议应解读为基于专家共识的建议,尤其在缺乏高质量证据的部分。
证据类型、等级与局限
- 证据类型:专家共识立场声明。
- 推荐强度:基于专家共识的建议。
- 局限:原文未报告局限性。
对床旁实践的改变
- 声明旨在改善AION的早期发现、病因管理及视觉和全身并发症的预防。
- 声明特别强调内科医生在AION患者照护中的作用。
- 声明强调眼科与内科紧密协作对AION综合协调管理至关重要。
指南或共识出处
- 前部缺血性视神经病变(AION)联合立场声明,由西班牙内科学会(SEMI)血管风险组与全身自身免疫病组(GEAS)及西班牙视网膜与玻璃体学会(SERV)联合发布,发表于Rev Clin Esp (Barc)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Anterior ischemic optic neuropathy (AION) is one of the leading causes of sudden, painless, monocular vision loss in individuals over 50 years of age. Two forms can be distinguished, with clearly different clinical, diagnostic, and therapeutic implications: the arteritic form, most commonly associated with giant cell arteritis (GCA), which constitutes a medical and ophthalmological emergency; and the non-arteritic form, which is far more frequent and for which no specific effective treatment is currently available. Despite its clinical relevance and the frequent coexistence of vascular risk factors, the management of AION remains heterogeneous, with considerable variability in care pathways, etiological assessment, and follow-up and secondary prevention strategies. This situation highlights the need for a comprehensive and coordinated approach, in which close collaboration between Ophthalmology and Internal Medicine is essential. This position statement is part of a series of joint working groups documents promoted by the Vascular Risk Group of the Spanish Society of Internal Medicine (SEMI) and the Spanish Retina and Vitreous Society (SERV), which began with the consensuses on retinal arterial and venous occlusion. Internists with extensive experience in vasculitis and systemic diseases, who are members of the Systemic Autoimmune Diseases Group (GEAS), have participated in the preparation of this text. The aim is to establish a consensus-based proposal for the clinical management of AION. The epidemiological, pathophysiological, diagnostic and therapeutic aspects of the disease are critically reviewed, and practical recommendations are provided to improve early detection, etiological management and the prevention of visual and systemic complications, with particular emphasis on the role of the internist in the care of these patients. The recommendations included in this document should be interpreted as expert consensus-based recommendations, particularly in those sections where high‑quality evidence is lacking.
参考来源
- Jaén Águila F, Gómez Escobar AJ, Navarrete Navarrete N, et al. Joint position paper on anterior ischemic optic neuropathy (AION). Vascular Risk Group and Systemic Autoimmune Diseases Group (GEAS) of the Spanish Society of Internal Medicine (SEMI) together with the Spanish Retina and Vitreous Society (SERV). Rev Clin Esp (Barc). 2026. PMID: 42710617. doi:10.1016/j.rceng.2026.502615
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。